Clinical Trial Update: Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease [Phase 2]

View source ↗

Summary

Phase II randomized trial of collagenase for residual Dupuytren's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dupuytren Contracture

Drugs mentioned

• Collagenase (collagenase)

Snippet

Sponsor: State University of New York | Conditions: Dupuytren's Contracture | Phase 2 | Status: COMPLETED